Protalix BioTherapeutics, Inc.
PLX· NYSE
Protalix BioTherapeutics, Inc.
- Last sale
- Oct 1, 2026 · -3.09%
- Market cap
- $215.13M
- 80.57M shares
- Filings
- 971
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $52,744,000 | reported | |
| FY 2024 | 2024-12-31 | $53,399,000 | reported | |
| FY 2023 | 2023-12-31 | $65,494,000 | reported | |
| FY 2022 | 2022-12-31 | $47,638,000 | reported | |
| FY 2021 | 2021-12-31 | $38,350,000 | reported | |
| FY 2020 | 2020-12-31 | $62,898,000 | reported | |
| FY 2019 | 2019-12-31 | $54,693,000 | reported | |
| FY 2018 | 2018-12-31 | $34,240,000 | reported | |
| FY 2017 | 2017-12-31 | $21,078,000 | reported | |
| FY 2016 | 2016-12-31 | $9,199,000 | reported | |
| FY 2015 | 2015-12-31 | $4,364,000 | reported | |
| FY 2014 | 2014-12-31 | $3,523,000 | reported |
Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR
